Neuromodulation Devices Market Research Report ‚Äď Forecast to 2030

Neuromodulation Devices Market Share, Growth and Insights By Type (Internal, External), Application (SCS, DBS, VNS, SNS, GES, TENS, TMS), Biomaterial (Metallic, Polymeric, Ceramic), End-User (Hospitals, Clinics, Homecare) ‚Äď Forecast Till 2030

ID: MRFR/MED/0829-HCR | 115 Pages | Published By Kinjoll Dey on March 2023         

Neuromodulation Devices Market Speak to Analyst Request a Free Sample

Neuromodulation Devices Market

Neuromodulation Devices is expected to reach USD 14.2 billion with a CAGR of 11.5% during the forecast period of 2022‚Äď2030.

Segmentation
By Type Internal External
By Application SCS DBS VNS SNS GES TENS TMS
By Biomaterial Metallic Polymeric Ceramic
By End-User Hospitals Clinics Homecare
Key Players
Companies Profiled   Nevro Corporation (U.S.)   LivaNova PLC (UK)   Boston Scientific Corporation (US)   Aleva Neurotherapeutics SA (US)   Bioness Inc. (US)   EnteroMedics Inc (US)   Neuronetics Inc. (US)   Cyberonics Inc. (US)   Jude Medical Inc. (U.S.)   Accellent (US)   DynaMD (US)
Drivers
Market Driving Forces   Rising health problems   Increasing number of health problems due to the pandemic.
Request a Free Sample

Neuromodulation Devices Market Overview


The neuromodulation devices market size is projected to reach USD 14.2 Billion by 2030 at 11.5% CAGR during the forecast period 2022-2030. Neuromodulation is a technology that is used for the modulation of nerve activity by using electrical stimulation to a specific part of the body. This technology is used to treat various types of diseases. Neuromodulation devices are used for this process, and they work through electrical stimulation. The Neuromodulation medical devices are used with the application of electrodes to the peripheral nerves, brain, and spinal cord. The electrode in the Medtronic Neuromodulation devices are connected with the help of an extension cable to the power source and pulse generator, and it helps to generate enough electrical impulses. With the use of this device, a low-voltage electrical signal passes to the nerves and stimulates the neural impulses where they were not available previously.


Neuromodulation devices ‚Äėneurostim‚Äô are used to improve the quality of life of people suffering from various conditions, psychological disorders, chronic pain, essential tremor, urinary and fecal incontinence, dystonia. Neuromodulation devices for shoulder pain are also available on the market. Apart from that, pediatric Neuromodulation devices and Neuromodulation devices for TBI are in huge demand with increasing diseases in children and brain injuries. The conditions are permanent, so the clinical period for Neuromodulation devices is long-term. The rise in neurological disorders will drive the market growth. Neuromodulation therapy devices can directly work on the nerves, and they can alter the nerve activity to a target area by sending an electrical agent to the area. Neuromodulation devices can treat almost every disease, and it will increase the Neuromodulation devices market trends.


Rise in the research if the application of the Neuromodulation devices will act as a major factor for the Neuromodulation devices market growth. Also, increasing number variety of headaches, brain diseases, and neurological disorders, also the adoption of Neuromodulation devices to treat depression and sleep problems, increasing chronic and gastric diseases, and rising number of Neuromodulation device manufacturers and Neuromodulation device companies will boost the market size in the forecast period. Also increasing number of spinal cord problems will boost the spinal cord stimulation devices market in the coming years. The electrical stimulation devices market will rise to treat different types of problems associated with brain injury, and it will propel the Neuromodulation market size. The global Neuromodulation Devices industry will see rapid growth in demand in the forecast period with the rising application of Neuromodulation devices to treat diseases.


Covid-19 analysis


The covid-19 pandemic outbreak was due to the rapid spread of coronavirus. Many regions in the world were highly affected due to the spread of this virus. Still, the countries haven’t recovered from this virus, and the new variant of the virus has become a major problem for the countries. Business organizations and countries are facing problems as the global economy is down. Many sectors are highly affected due to the pandemic, apart from the healthcare sector. The healthcare sectors are showing high demand due to this pandemic, and the reason is obvious. The healthcare sector will increase more with the increasing number of health problems due to the pandemic. Neuromodulation devices are used in the treatment of varieties of diseases. Many people have experienced major health problems after recovering from the virus; as a result, it will drive the market demand of the Neuromodulation devices. But due to the imposition of lockdown, the Neuromodulation devices are likely to face problems in the production sector.


Market Dynamics


Market drivers


There are various factors that drive the market of neuromodulation devices globally. Rising health problems are one of the major factors that are driving the market. Neuromodulation devices for chronic pain, shoulder pain, headache, and brain Injury have gained so much popularity over the years due to their unique ability to provide comfort in these types of diseases. Neuromodulation devices are also used in treating depression, gastric, and sleeping problems. So, the wide application of Neuromodulation devices to treat various types of diseases is driving the Neuromodulation devices industry. According to research, 5.3 million people were suffering from Alzheimer’s in America. Generic diseases are expected to increase in the developed countries, and the government and private initiatives to treat neurological disorders and mental health will propel the market globally. Also, the new technology offered by the market players to prevent neurological diseases is expected to drive the Neuromodulation devices market growth over the forecast period. Additionally, the increasing economics and per capita income of people will create significant growth in the Neuromodulation devices industry.


Market opportunities


The medical devices agency in Japan has approved many Neuromodulation devices for pain management, and the rise in the approval rate by the medical devices agency across various countries will generate more opportunities for the market. Also, the adoption of advanced technology in treating various diseases and rising diseases will also bring more opportunities for the Neuromodulation devices industry. Raising research and Neuromodulation device development will further create new opportunities for the internal market of neuromodulation devices during the forecast period.


Market restraints


There are many factors that are hampering the growth of the market. The major restraint for the market is high capital investment. The high investment to make Neuromodulation devices is creating a problem for the new key players, and it has become a major restraint for the market. Apart from that, the Use of Neuromodulation devices require highly skilled professional, and the lack of trained professional is a restraint for the market of Neuromodulation devices.


Market challenges


There are many challenges faced by the Neuromodulation devices market, just like other markets. The high cost of the Neuromodulation process and government regulations on the use of Neuromodulation devices are a major challenge for the Neuromodulation devices industry. Apart from that, the underdeveloped areas don’t have enough funds or availability of advanced technology, and it is another challenge for the market. The key players are trying to overcome these challenges to boost the market demand in the forecast period.


Market segmentation


The Neuromodulation devices market is segmented on the basis of type, application, biomaterial, and end-user.



  • By type- Based on type, the market further carried out into internal Neuromodulation and external Neuromodulation. Internal Neuromodulation is further divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. The external Neuromodulation is further divided into transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, respiratory electrical stimulation.

  • By application-¬†By application, the¬†is divided into spinal cord stimulation and spinal cord stimulation.

  • By biomaterial-¬†On the basis of biomaterial, the¬†market¬†is divided into metallic biomaterials, ceramic biomaterials, and polymeric biomaterials.

  • By end-user-¬†The end-user segment of the¬†market¬†is divided into hospitals, home healthcare, and clinics.


Regional analysis


The major regions in the Neuromodulation devices market are North America, Europe, Asia Pacific, and the rest of the world. North America holds the highest share in the market due to the presence of big Neuromodulation companies in US. Also, many people are suffering from chronic pain, epilepsy, mad other diseases, and it will drive the market in this region. This region was responsible for 55% of global Neuromodulation devices in 2017. Europe is the second-largest following to North America due to the growing number of Neuromodulation devices in this region. The Asia Pacific region will register the highest CAGR rate due to the fastest-growing countries like China and India. Japan has the highest share in this region. China will grow at a faster rate owing to its largest manufacturing base and increasing population. India will also see rapid growth in the future due to increasing investment and awareness regarding mental problems. The middle East and Africa see moderate growth due to the increasing number of Neuromodulation devices manufacturers.


Competitive landscape


The major key players in the Neuromodulation Devices market are:



  • Nevro Corporation (U.S.)¬†

  • LivaNova PLC (UK)¬†

  • Boston Scientific Corporation (US)¬†

  • Aleva Neurotherapeutics SA (US)¬†

  • Bioness Inc. (US), EnteroMedics Inc (US)

  • Neuronetics, Inc. (US)¬†

  • Cyberonics, Inc. (US)¬†

  • Jude Medical, Inc. (U.S.)¬†

  • Accellent (US)¬†

  • DynaMD (US)¬†

  • BioControl Medical (Israel)¬†

  • NeuroPace Inc. (US)¬†

  • Synapse Biomedical, Inc. (US)¬†

  • Neurosigma, Inc. (US.)

  • Soterix Medical, Inc. (US)¬†


Recent developments


Neuroelectrics permitted FDA breakthrough device designation for a new Therapeutic Neuromodulation Platform for the treatment of refractory focal epilepsy.



Report Scope:

Report Attribute/Metric Details
  Market Size   14.2 Billion
  CAGR   11.5%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Type by Application, Biomaterial, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   St. Jude Medical, Inc. (U.S.), LivaNova PLC (UK), Boston Scientific Corporation (U.S.), Aleva Neurotherapeutics SA (U.S.), Bioness Inc. (U.S.), EnteroMedics Inc (U.S.), Nevro Corporation (U.S.), NeuroPace Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Neurosigma, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), BioControl Medical (Israel), Accellent (U.S.), DynaMD (U.S.), Soterix Medical, Inc. (U.S.), and others.
  Key Market Opportunities   The expansion in emerging economies
  Key Market Drivers

  • Extended new indications
  • Target applications coupled with the robust product pipeline offered by players
  • Increasing prevalence of neurological diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Neuromodulation Devices Market size is projected to reach USD 14.2 Billion by 2030 at 11.5% CAGR during the forecast period

    St. Jude Medical, Inc. (U.S.), LivaNova PLC (UK), Boston Scientific Corporation (U.S.), Aleva Neurotherapeutics SA (U.S.), Bioness Inc. (U.S.), EnteroMedics Inc (U.S.), Nevro Corporation (U.S.), NeuroPace Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Neurosigma, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), BioControl Medical (Israel), Accellent (U.S.), DynaMD (U.S.), Soterix Medical, Inc. (U.S.) are the key players in the market

    The Americas Would Dominate The Neuromodulation Devices Market.

    The Asia Pacific Neuromodulation Devices Market Would Grow With The Fastest Speed.

    The Segments Are Internal Neuromodulation And External Neuromodulation (Non-Invasive).

    Factors Like Lack Of Trained Professionals, Stringent Government Regulations, Barriers For New Players Due To High Capital Investment, And Unfavorable Reimbursement Scenario Could Hold Back The Neuromodulation Devices Market.